Close

Tag: Coronavirus information (COVID-19)

Agilex Biolabs Toxicology Tapped for SARS-CoV-2 Vaccine Research

Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, said biotechs with first-in-human studies can leverage significant quality, speed...

Union therapy-A Preventive medicine model to combat COVID-19 and future threats

Kanishk Kala1 Rupinder Kaur Sodhi2 CCP Mohali IK Gujral PTU COVID-19 has become a global threat with immense mortality and morbidity in India.1The efforts of...

India’s Biological E. to produce J&J COVID-19 vaccine

India's Biological E. will produce the Johnson & Johnson COVID-19 vaccine alongside its own candidate, which could boost the country's overall supplies amid a...

Natco Pharma signs voluntary licensing agreement with Lilly for baricitinib for Covid-19 in India

Natco Pharma Limited announced the signing of a royalty-free, non-exclusive, voluntary licensing agreement with Eli Lilly and Company, for the manufacture and commercialization of...

LANXESS India continues to support fight against COVID-19 through its CSR initiatives

LANXESS India has committed over INR 2.1 crores as part of its CSR spends to support the medical infrastructure in the country in its...

Dr. Reddy’s Laboratories enters into a Voluntary Licensing Agreement with Lilly to Expand Access to COVID-19 Treatment in India

Dr. Reddy's Laboratories Ltd. announced that it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company ("Lilly") for the...

WHO classifies India Covid strain as ‘variant of concern’

The B-1617 variant of coronavirus, first identified in India, has been classified as a “variant of concern” at the global level by the World...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read